Journal article icon

Journal article

Effectiveness of physio-cognitive dual-task training on improving global cognition, health-related quality of life, and physical outcomes among older adults with neurocognitive disorders: an umbrella review

Abstract:
Background: Physio-cognitive dual-task training (PCDT), combining physical and cognitive tasks, is a promising approach. However, clarity regarding its effectiveness and evidence credibility remains limited. Objective: To evaluate PCDT effectiveness on global cognition, health-related quality of life, and physical outcomes (activities of daily living, gait, balance) in older adults with neurocognitive disorders, assess review quality and evidence certainty, and explore moderator effects. Methods: Eight databases and grey literature were searched to 31 December 2024. Two reviewers independently screened, extracted data, and assessed review quality (AMSTAR-2) and evidence certainty (GRADE). Meta-level and study-level meta-analyses were conducted. Subgroup analyses and meta-regression explored moderator effects. PROSPERO: CRD42024622115. Results: Seventeen reviews with 47 unique meta-analyses involving 81 unique studies were included. Meta-level analyses indicated small significant improvements across outcomes except health-related quality of life. Study-level analyses, correcting for overlapping primary studies, confirmed significant benefits for global cognition and health-related quality of life; however, physical outcome effects were non-significant. Prediction intervals for all outcomes were non-significant. Simultaneous PCDT and higher weekly frequency showed greater benefits. Participants with dementia benefited less than those with mild cognitive impairment. Age was not a significant moderator. Most reviews were low or critically low quality, and evidence certainty was low. Conclusions: PCDT is potentially associated with improvements in cognitive, physical, and quality-of-life outcomes among older adults with neurocognitive disorders. However, prediction intervals suggest effectiveness uncertainty, and heavy sample weighting toward prodromal stages warrants caution. PCDT may not be indicated for cognitive improvement in established dementia. High-quality reviews are urgently needed.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1093/ageing/afag061

Authors

More by this author
Role:
Author
ORCID:
0009-0001-5432-4305
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Women's & Reproductive Health
Sub department:
NPEU
Role:
Author
ORCID:
0000-0002-5338-578X
More by this author
Role:
Author
ORCID:
0009-0004-3671-642X
More by this author
Role:
Author
ORCID:
0000-0002-6410-8681


Publisher:
Oxford University Press
Journal:
Age and Ageing More from this journal
Volume:
55
Issue:
3
Article number:
afag061
Publication date:
2026-03-27
Acceptance date:
2026-02-06
DOI:
EISSN:
1468-2834
ISSN:
0002-0729


Language:
English
Keywords:
Pubs id:
2400127
Local pid:
pubs:2400127
Source identifiers:
3893444
Deposit date:
2026-03-27
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP